Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial

Table 2 Anthropometric variables in diabetic patients with NAFLD

Anthropometric variables	Omega-3 (n = 30)	Placebo (n = 30)	P	P^†
Weight, kg			0.71	0.61
Baseline	78.0 ± 10.5	77.1 ± 12.5
Week 12	78.0 ± 11.1	76.8 ± 13.8
Mean change	0.0 ± 2.3	− 0.3 ± 2.3
BMI, kg/m²			0.59	0.56
Baseline	30.2 ± 3.6	29.8 ± 4.2
Week 12	30.2 ± 3.7	29.6 ± 4.5
Mean change	0.0 ± 0.8	−0.2 ± 0.8
WC, cm			0.59	0.27
Baseline	106.7 ± 9.1	104.2 ± 9.8
Week 12	106.1 ± 8.2	104.8 ± 9.6
Mean change	−0.7 ± 3.7	0.6 ± 3.2

P values are computed by independent t-test and data are expressed as mean ± standard deviation (SD)
P: resulted from comparing the means of each variable at the end of the study, between two groups
P^†: resulted from comparing the mean change from baseline between groups
NAFLD Non-alcoholic fatty liver disease, BMI Body mass index, WC Waist circumference

ISSN: 2055-0928